Mglobal

Mglobal was established in 2025, with its headquarters in Hong Kong, China, and offices in Kuala Lumpur and Changsha, forming a "three-location linkage, internal and external collaboration" structure. The company has deeply cultivated core markets such as ASEAN, focusing on innovative sectors like in-vitro diagnostics, hemodialysis, intraocular lenses, minimally invasive surgical instruments, and specialized wound care materials, while covering the full range of medical consumables. It has already partnered with over 10 listed Chinese medical companies, using Malaysia as a hub in ASEAN to cover key channels including local public/private healthcare groups and regulatory agencies, achieving precise alignment between Chinese medical production capacity and Southeast Asian demand.